0.2012 USD
0 (-1.85%)
0.1951 USD
-0.01 (-3.03%)
ChartMill assigns a Buy % Consensus number of 46% to EPIX. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 1.73. This target is 761.83% above the current price.
- EPIX was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about EPIX.
- In the previous month the buy percentage consensus was at a similar level.
- EPIX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-04 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2024-11-04 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-11-01 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-05-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2023-12-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2023-08-09 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2022-05-12 | Piper Sandler | Maintains | Overweight |
| 2021-08-17 | Oppenheimer | Maintains | Outperform |
| 2021-03-04 | Piper Sandler | Initiate | Overweight |
| 2021-02-25 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-11 | HC Wainwright & Co. | Maintains | Buy |
ESSA Pharma Inc / EPIX FAQ
What is the price target for EPIX stock?
7 analysts have analysed EPIX and the average price target is 1.73 USD. This implies a price increase of 761.83% is expected in the next year compared to the current price of 0.2012.
What is the consensus rating for EPIX stock?
The consensus rating for ESSA Pharma Inc (EPIX) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.